Engene Therapeutics (ENGN)'s 30-day implied volatility (IV30) was 75.7% at the close on October 30, 2026, down from 89.3% the day before, against a 52-week range of 50.2% to 142.5%. Its 20-day historical volatility was 66.7%.
Data as of October 30, 2026.